BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 29374275)

  • 21. The genetic spectrum of familial hypercholesterolemia in south-eastern Poland.
    Sharifi M; Walus-Miarka M; Idzior-Waluś B; Malecki MT; Sanak M; Whittall R; Li KW; Futema M; Humphries SE
    Metabolism; 2016 Mar; 65(3):48-53. PubMed ID: 26892515
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Next generation sequencing to identify novel genetic variants causative of autosomal dominant familial hypercholesterolemia associated with increased risk of coronary heart disease.
    Al-Allaf FA; Athar M; Abduljaleel Z; Taher MM; Khan W; Ba-Hammam FA; Abalkhail H; Alashwal A
    Gene; 2015 Jul; 565(1):76-84. PubMed ID: 25839937
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical Genetic Testing for Familial Hypercholesterolemia: JACC Scientific Expert Panel.
    Sturm AC; Knowles JW; Gidding SS; Ahmad ZS; Ahmed CD; Ballantyne CM; Baum SJ; Bourbon M; Carrié A; Cuchel M; de Ferranti SD; Defesche JC; Freiberger T; Hershberger RE; Hovingh GK; Karayan L; Kastelein JJP; Kindt I; Lane SR; Leigh SE; Linton MF; Mata P; Neal WA; Nordestgaard BG; Santos RD; Harada-Shiba M; Sijbrands EJ; Stitziel NO; Yamashita S; Wilemon KA; Ledbetter DH; Rader DJ;
    J Am Coll Cardiol; 2018 Aug; 72(6):662-680. PubMed ID: 30071997
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetics of familial hypercholesterolemia.
    Brautbar A; Leary E; Rasmussen K; Wilson DP; Steiner RD; Virani S
    Curr Atheroscler Rep; 2015 Apr; 17(4):491. PubMed ID: 25712136
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Toward a new clinical classification of patients with familial hypercholesterolemia: One perspective from Spain.
    Masana L; Ibarretxe D; Rodríguez-Borjabad C; Plana N; Valdivielso P; Pedro-Botet J; Civeira F; López-Miranda J; Guijarro C; Mostaza J; Pintó X;
    Atherosclerosis; 2019 Aug; 287():89-92. PubMed ID: 31238171
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Portuguese Familial Hypercholesterolemia Study: presentation of the study and preliminary results.
    Bourbon M; Rato Q;
    Rev Port Cardiol; 2006 Nov; 25(11):999-1013. PubMed ID: 17274457
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Functional characterization of mutant genes associated with autosomal dominant familial hypercholesterolemia: integration and evolution of genetic diagnosis.
    Di Taranto MD; D'Agostino MN; Fortunato G
    Nutr Metab Cardiovasc Dis; 2015 Nov; 25(11):979-87. PubMed ID: 26165249
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The study of familial hypercholesterolemia in Italy: A narrative review.
    Bertolini S; Pisciotta L; Fasano T; Rabacchi C; Calandra S
    Atheroscler Suppl; 2017 Oct; 29():1-10. PubMed ID: 28965614
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lipoprotein(a) in hereditary hypercholesterolemia: Influence of the genetic cause, defective gene and type of mutation.
    Marco-Benedí V; Cenarro A; Laclaustra M; Larrea-Sebal A; Jarauta E; Lamiquiz-Moneo I; Calmarza P; Bea AM; Plana N; Pintó X; Martín C; Civeira F
    Atherosclerosis; 2022 May; 349():211-218. PubMed ID: 34456049
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New Approaches in Detection and Treatment of Familial Hypercholesterolemia.
    Hartgers ML; Ray KK; Hovingh GK
    Curr Cardiol Rep; 2015 Dec; 17(12):109. PubMed ID: 26482752
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mutational Spectrum of
    Moradi A; Maleki M; Ghaemmaghami Z; Khajali Z; Noohi F; Moghadam MH; Kalyinia S; Mowla SJ; Seidah NG; Malakootian M
    Front Genet; 2021; 12():625959. PubMed ID: 33732287
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular characterization of familial hypercholesterolemia in Spain.
    Palacios L; Grandoso L; Cuevas N; Olano-Martín E; Martinez A; Tejedor D; Stef M
    Atherosclerosis; 2012 Mar; 221(1):137-42. PubMed ID: 22244043
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analysis of Children and Adolescents with Familial Hypercholesterolemia.
    Minicocci I; Pozzessere S; Prisco C; Montali A; di Costanzo A; Martino E; Martino F; Arca M
    J Pediatr; 2017 Apr; 183():100-107.e3. PubMed ID: 28161202
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Homozygous Familial Hypercholesterolemia in Spain: Prevalence and Phenotype-Genotype Relationship.
    Sánchez-Hernández RM; Civeira F; Stef M; Perez-Calahorra S; Almagro F; Plana N; Novoa FJ; Sáenz-Aranzubía P; Mosquera D; Soler C; Fuentes FJ; Brito-Casillas Y; Real JT; Blanco-Vaca F; Ascaso JF; Pocovi M
    Circ Cardiovasc Genet; 2016 Dec; 9(6):504-510. PubMed ID: 27784735
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of mutations in LDLR and PCSK9 genes on phenotypic variability in Tunisian familial hypercholesterolemia patients.
    Slimani A; Jelassi A; Jguirim I; Najah M; Rebhi L; Omezzine A; Maatouk F; Hamda KB; Kacem M; Rabès JP; Abifadel M; Boileau C; Rouis M; Slimane MN; Varret M
    Atherosclerosis; 2012 May; 222(1):158-66. PubMed ID: 22417841
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Improvement of Definite Diagnosis of Familial Hypercholesterolemia Using an Expanding Genetic Analysis.
    Cao YX; Sun D; Liu HH; Jin JL; Li S; Guo YL; Wu NQ; Zhu CG; Liu G; Dong Q; Sun J; Chen XH; Li JJ
    JACC Asia; 2021 Jun; 1(1):82-89. PubMed ID: 36338372
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetic heterogeneity of autosomal dominant hypercholesterolemia in Mexico.
    Robles-Osorio L; Huerta-Zepeda A; Ordóñez ML; Canizales-Quinteros S; Díaz-Villaseñor A; Gutiérrez-Aguilar R; Riba L; Huertas-Vázquez A; Rodríguez-Torres M; Gómez-Díaz RA; Salinas S; Ongay-Larios L; Codiz-Huerta G; Mora-Cabrera M; Mehta R; Gómez Pérez FJ; Rull JA; Rabès JP; Tusié-Luna MT; Durán-Vargas S; Aguilar-Salinas CA
    Arch Med Res; 2006 Jan; 37(1):102-8. PubMed ID: 16314194
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetic Diagnosis of Familial Hypercholesterolemia in Asia.
    Huang CC; Charng MJ
    Front Genet; 2020; 11():833. PubMed ID: 32793292
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetic diagnosis of familial hypercholesterolaemia using a rapid biochip array assay for 40 common LDLR, APOB and PCSK9 mutations.
    Martin R; Latten M; Hart P; Murray H; Bailie DA; Crockard M; Lamont J; Fitzgerald P; Graham CA
    Atherosclerosis; 2016 Nov; 254():8-13. PubMed ID: 27680772
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Elevated plasma PCSK9 level is equally detrimental for patients with nonfamilial hypercholesterolemia and heterozygous familial hypercholesterolemia, irrespective of low-density lipoprotein receptor defects.
    Lambert G; Petrides F; Chatelais M; Blom DJ; Choque B; Tabet F; Wong G; Rye KA; Hooper AJ; Burnett JR; Barter PJ; Marais AD
    J Am Coll Cardiol; 2014 Jun; 63(22):2365-73. PubMed ID: 24632287
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.